Caffeine: cognitive and physical performance enhancer or psychoactive drug?
about
Coffee Consumption and Oxidative Stress: A Review of Human Intervention StudiesStructure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the DrawbacksDecreased Caffeine-Induced Locomotor Activity via Microinjection of CART Peptide into the Nucleus Accumbens Is Linked to Inhibition of the pCaMKIIa-D3R InteractionMoral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts.Caffeine Use in Military Personnel With PTSD: Prevalence and Impact on Sleep.A Randomized, Two-Way Crossover Study to Evaluate the Pharmacokinetics of Caffeine Delivered Using Caffeinated Chewing Gum Versus a Marketed Caffeinated Beverage in Healthy Adult Volunteers.Coffee consumption and disease correlations.The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.Red Bull® energy drink increases consumption of higher concentrations of alcohol.Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism.Does caffeine influence the anticholinesterase and antioxidant properties of donepezil? Evidence from in vitro and in vivo studies.Caffeine consumption disrupts hippocampal long-term potentiation in freely behaving rats.Caffeine and Modafinil Ameliorate the Neuroinflammation and Anxious Behavior in Rats during Sleep Deprivation by Inhibiting the Microglia Activation.Caffeine Protects Dopaminergic Neurons From Dopamine-Induced Neurodegeneration via Synergistic Adenosine-Dopamine D2-Like Receptor Interactions in Transgenic Caenorhabditis elegans.Morphometric changes over the whole brain in caffeine-containing combination-analgesic-overuse headache.Caffeine-Related Deaths: Manner of Deaths and Categories at Risk.Xanthine scaffold: scope and potential in drug development
P2860
Q26740018-AE3A3C67-A18B-4D8A-B2DA-19C66C3A3415Q26740559-BF510139-5EC4-45E8-A098-EC5953A360A3Q27334685-BDFDEE61-9FDB-40ED-AB78-AF817167301DQ35973078-107BE9EC-F4A7-4608-986E-FA578BD47F25Q40161965-1B4A30E1-114F-4BDB-87C9-A38A410C8747Q47150400-2843077D-DC62-4E3E-83CB-A7BB23FAC4A7Q47195821-8DEE6DB7-0FBE-4760-B0BA-78E0BDE4B1F9Q47669851-AD3956A9-CC8C-4BCC-B953-A055B04E4889Q48053283-A95C6476-F503-4825-BD17-95C5878CBDF7Q48354017-DCE5C8AE-B20B-47F8-B8D9-482B7D61C317Q48355413-A232002E-DA57-4DAF-932E-202AE1325DB1Q50420575-95B30E82-B44D-461B-AFEA-A7041A8F295FQ52620604-87DA586C-E3A0-4BEF-86DD-126FCAD62D52Q54975826-3877DDDB-29DB-4651-9F65-2BD765BC9165Q55033375-B9FBF843-FBE2-4638-8CED-07448089CF42Q55155716-B2ED4B4C-DF43-4B0C-A3C3-80B999711A0EQ57298107-4F059052-828F-4723-B7DB-23F10464A7EB
P2860
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@ast
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@en
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@nl
type
label
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@ast
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@en
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@nl
prefLabel
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@ast
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@en
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@nl
P2093
P2860
P31
P3181
P1476
Caffeine: cognitive and physical performance enhancer or psychoactive drug?
@en
P2093
Gabriele Sani
Mariarosaria Aromatario
Simone Cappelletti
P2860
P3181
P356
10.2174/1570159X13666141210215655
P407
P577
2015-01-01T00:00:00Z